Syndax Pharmaceuticals Inc (SNDX) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 35 days, typically, give or take 12 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Mon, Nov 2, 2026after close 33 8-K
Q2 FY2026Tue, Aug 4, 2026after close 35 8-K
Q1 FY2026Thu, Apr 30, 2026after close 30 8-K
Q4 FY2025Thu, Feb 26, 2026after close 57 8-K
Q3 FY2025Mon, Nov 3, 2025after close 34 8-K
Q2 FY2025Mon, Aug 4, 2025after close 35 8-K
Q1 FY2025Mon, May 5, 2025after close 35 8-K
Q4 FY2024Mon, Mar 3, 2025before open 62 8-K

What they guided beta

Q3 FY2026 "The Company expects to have a major presence at upcoming medical meetings, with the presentation in the fourth quarter of 2026 of new/updated revumenib data including:" exhibit
Q3 FY2026 "The Company expects to publish safety and efficacy data from R/R NUP98r acute leukemia patients treated with revumenib in the fourth quarter of 2026." exhibit
Q3 FY2026 "The Company expects the RAVEN trial to initiate in the fourth quarter of 2026." exhibit
Q3 FY2026 "The Company expects the MenTain Phase 2 trial to initiate in the first quarter of 2027." exhibit
Q3 FY2026 "The Company expects topline data from the Phase 2 trial of axatilimab in combination with ruxolitinib to be presented at a medical meeting in the first quarter of 2027." exhibit
Q2 FY2026 "We also have multiple near-term catalysts with Niktimvo Phase 2 data in IPF and frontline cGVHD expected in the fourth quarter, plus additional practice-informing and" exhibit
Q2 FY2026 "The Company expects to have a major presence at upcoming medical meetings in the second half of 2026 with the presentation of new/updated revumenib data including:" exhibit
Q2 FY2026 "The Company expects the RAVEN trial to initiate in the second half of 2026." exhibit
Q2 FY2026 "The Company expects the MenTain Phase 2 trial to initiate around the end of 2026." exhibit
Q2 FY2026 "The Company expects to publish safety and efficacy data from R/R NUP98r acute leukemia patients treated with revumenib in the fourth quarter of 2026." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/SNDX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/SNDX

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

SNDX earnings date badge

HTML

<a href="https://veritasdata.dev/company/SNDX/"><img src="https://veritasdata.dev/embed/SNDX.svg" alt="SNDX earnings date" width="240" height="56"></a>

Markdown

[![SNDX earnings date](https://veritasdata.dev/embed/SNDX.svg)](https://veritasdata.dev/company/SNDX/)

Script

<script async src="https://veritasdata.dev/embed/SNDX.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/SNDX"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.